Charles River Laboratories International, Inc.

NYSE:CRL 株式レポート

時価総額:US$10.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Charles River Laboratories International 配当金

配当金 基準チェック /06

Charles River Laboratories International配当金を支払った記録がありません。

主要情報

n/a

配当利回り

n/a

配当性向

業界平均利回り0.4%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
一株当たり利益US$8.63
3年後の配当利回り予想0%

最近の配当金アップデート

更新なし

Recent updates

Charles River Laboratories: Fair Valuation Against Fundamentals

May 31

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

May 25
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?

Apr 27
Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?

Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings

Apr 11
Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings

Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet

Mar 27
Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet

Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues

Feb 21
Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues

Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'

Feb 16

Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?

Jan 17
Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?

Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up

Jan 02
Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up

Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth

Dec 17
Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth

Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation

Nov 26

Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?

Nov 12
Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?

Charles River: Q3 Points To Ongoing Deterioration

Nov 09

Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet

Oct 27
Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet

At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?

Oct 12
At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?

Charles River Laboratories: Diving Into The Lab (Rating Upgrade)

Oct 06

Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?

Aug 10
Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?

Charles River Laboratories: Very Attractive After The Pullback

Jul 26

Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?

Jul 22
Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?

Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly

Jul 03
Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly

When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?

Jun 19
When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?

A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

May 01
A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?

Apr 16
Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?

These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well

Apr 02
These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well

Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?

Mar 19
Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?

Charles River gains as Guggenheim upgrades despite post-earnings selloff

Feb 23

Charles River Laboratories International: A Great Business At A Decent Price

Feb 06

Charles River acquires SAMDI Tech for $50M in cash

Jan 30

Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth US$253 Based On Its Intrinsic Value?

Jan 24
Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth US$253 Based On Its Intrinsic Value?

If EPS Growth Is Important To You, Charles River Laboratories International (NYSE:CRL) Presents An Opportunity

Jan 10
If EPS Growth Is Important To You, Charles River Laboratories International (NYSE:CRL) Presents An Opportunity

Charles River Laboratories sells Avian Vaccine Services business to Arlington Capital

Jan 05

We Think Charles River Laboratories International (NYSE:CRL) Can Stay On Top Of Its Debt

Dec 28
We Think Charles River Laboratories International (NYSE:CRL) Can Stay On Top Of Its Debt

Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?

Dec 14
Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?

決済の安定と成長

配当データの取得

安定した配当: CRLの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: CRLの配当金が増加しているかどうかを判断するにはデータが不十分です。


配当利回り対市場

Charles River Laboratories International 配当利回り対市場
CRL 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (CRL)n/a
市場下位25% (US)1.5%
市場トップ25% (US)4.8%
業界平均 (Life Sciences)0.4%
3年後のアナリスト予想 (CRL)0%

注目すべき配当: CRLは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: CRLは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。


株主への利益配当

収益カバレッジ: CRLの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。


株主配当金

キャッシュフローカバレッジ: CRLが配当金を報告していないため、配当金の持続可能性を計算できません。


高配当企業の発掘